Label Image (Lbl530024441)
Montelukast Sodium
Product Images NDC 53002-4441
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 53002-4441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (Montelukast Fig1)
Figure 1 shows the change in height (in centimeters) from the randomization visit by scheduled week for different treatment groups. The plot includes the treatment group mean and the standard error of the mean. The x-axis represents the weeks on treatment, ranging from 9 to 56. The three treatment groups are Montelukast 5 mg (n=120), Beclomethasone 336 μg (n=119), and the Placebo (n=121). The standard errors of the treatment group means are mentioned to be too small to be visible on the plot.*
Figure2 (Montelukast Fig2)
Figure 2 shows the mean percent change from baseline in FEV (forced expiratory volume) in a U.S. trial comparing Montelukast Sodium to placebo. The trial included 40 participants in the Montelukast Sodium group and 270 participants in the placebo group. The graph displays the data at different weeks in the treatment period and the washout phase. The ANOVA model was used for analysis.*
Chemical Structure (Montelukast Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
